Document is current
Any future updates will be listed below
-
Authors
Lorentzon, Mattias https://orcid.org/0000-0003-0749-1431
Johansson, Helena
Harvey, Nicholas C.
Liu, Enwu
Vandenput, Liesbeth
Crandall, Carolyn J.
Cauley, Jane A.
LeBoff, Meryl S.
McCloskey, Eugene V.
Kanis, John A.
-
Funding
Funding for this research was provided by:
University of Gothenburg
- License Information
-
More Information
Article History
Received: 22 November 2021
Accepted: 22 June 2022
First Online: 14 July 2022
Declarations
:
: M. Lorentzon has received lecture fees from Amgen, Astellas, Lilly, Meda, Renapharma, UCB Pharma, and consulting fees from Amgen, Radius Health, UCB Pharma, Renapharma, and Consilient Health. J. A. Kanis has received grant support from Amgen, Lilly, and Radius Health. N. Harvey has received consultancy, lecture fees, and honoraria from Alliance for Better Bone Health, AMGEN, MSD, Eli Lilly, Servier, Shire, UCB, Kyowa Kirin, Consilient Healthcare, Radius Health, and Internis Pharma outside the scope of the submitted work. E. McCloskey has received research funding, consultancy, lecture fees, and/or honoraria from Amgen, AstraZeneca, Consilient Healthcare, Fresenius Kabi, GSK, Hologic, Internis, Lilly, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Servier, Synexus, UCB, Unilever, and Warner Chilcott. All other authors have no conflicts of interests.
